+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Biopharmaceuticals Contract Manufacturing Market by Product (Biologics, Biosimilar), Source (Mammalian, Microbial-Based Biologics or Non-Mammalian), Contract Type, Service, Scale of Operation, Therapeutic Applications - Forecast 2024-2030- Product Image
Global Biopharmaceuticals Contract Manufacturing Market by Product (Biologics, Biosimilar), Source (Mammalian, Microbial-Based Biologics or Non-Mammalian), Contract Type, Service, Scale of Operation, Therapeutic Applications - Forecast 2024-2030- Product Image
Sale

Global Biopharmaceuticals Contract Manufacturing Market by Product (Biologics, Biosimilar), Source (Mammalian, Microbial-Based Biologics or Non-Mammalian), Contract Type, Service, Scale of Operation, Therapeutic Applications - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5613012
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biopharmaceuticals Contract Manufacturing Market size was estimated at USD 37.49 billion in 2023, USD 43.43 billion in 2024, and is expected to grow at a CAGR of 16.34% to reach USD 108.17 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biopharmaceuticals Contract Manufacturing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopharmaceuticals Contract Manufacturing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceuticals Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., AGC Biologics, Ajinomoto Co., Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, FUJIFILM Diosynth Biotechnologies, INCOG BioPharma Services, JRS PHARMA GmbH + Co. KG, Lonza AG, Merck KGaA, Pressure BioSciences, ProBioGen AG, Rentschler Biopharma SE, Samsung Biologics, Thermo Fisher Scientific Inc., Toyobo Co., Ltd., and WuXi Biologics, Inc.

Market Segmentation & Coverage

This research report categorizes the Biopharmaceuticals Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Biologics
    • Biosimilar
  • Source
    • Mammalian
    • Microbial-Based Biologics or Non-Mammalian
  • Contract Type
    • Active Pharmaceutical Ingredient
    • Fill-and-Finished
  • Service
    • Analytical & Quality Control Studies
    • Fill & Finish Operations
    • Packaging
    • Process Development
  • Scale of Operation
    • Clinical
    • Commercial
  • Therapeutic Applications
    • Cardiovascular Diseases
    • Infectious Disease
    • Neurology
    • Oncology
    • Ophthalmology
    • Respiratory Disorder
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Biopharmaceuticals Contract Manufacturing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopharmaceuticals Contract Manufacturing Market?
  3. What are the technology trends and regulatory frameworks in the Biopharmaceuticals Contract Manufacturing Market?
  4. What is the market share of the leading vendors in the Biopharmaceuticals Contract Manufacturing Market?
  5. Which modes and strategic moves are suitable for entering the Biopharmaceuticals Contract Manufacturing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biopharmaceuticals Contract Manufacturing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising outsourcing by biopharmaceutical companies
5.1.1.2. Increasing Number of CMOs and Rising Investments in Advanced Manufacturing Technologies
5.1.1.3. Growing demand for biologics globally
5.1.2. Restraints
5.1.2.1. High cost of setting up a production facility for biopharmaceuticals
5.1.3. Opportunities
5.1.3.1. Increasing investments in biopharmaceutical R&D and manufacturing
5.1.3.2. Growing focus on speciality drugs
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements for CMOs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Biopharmaceuticals Contract Manufacturing Market, by Product
6.1. Introduction
6.2. Biologics
6.3. Biosimilar
7. Biopharmaceuticals Contract Manufacturing Market, by Source
7.1. Introduction
7.2. Mammalian
7.3. Microbial-Based Biologics or Non-Mammalian
8. Biopharmaceuticals Contract Manufacturing Market, by Contract Type
8.1. Introduction
8.2. Active Pharmaceutical Ingredient
8.3. Fill-and-Finished
9. Biopharmaceuticals Contract Manufacturing Market, by Service
9.1. Introduction
9.2. Analytical & Quality Control Studies
9.3. Fill & Finish Operations
9.4. Packaging
9.5. Process Development
10. Biopharmaceuticals Contract Manufacturing Market, by Scale of Operation
10.1. Introduction
10.2. Clinical
10.3. Commercial
11. Biopharmaceuticals Contract Manufacturing Market, by Therapeutic Applications
11.1. Introduction
11.2. Cardiovascular Diseases
11.3. Infectious Disease
11.4. Neurology
11.5. Oncology
11.6. Ophthalmology
11.7. Respiratory Disorder
12. Americas Biopharmaceuticals Contract Manufacturing Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Biopharmaceuticals Contract Manufacturing Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Biopharmaceuticals Contract Manufacturing Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player
16. Competitive Portfolio
16.1. Key Company Profiles
16.1.1. AbbVie, Inc.
16.1.2. AGC Biologics
16.1.3. Ajinomoto Co., Inc.
16.1.4. Boehringer Ingelheim International GmbH
16.1.5. Cambrex Corporation
16.1.6. FUJIFILM Diosynth Biotechnologies
16.1.7. INCOG BioPharma Services
16.1.8. JRS PHARMA GmbH + Co. KG
16.1.9. Lonza AG
16.1.10. Merck KGaA
16.1.11. Pressure BioSciences
16.1.12. ProBioGen AG
16.1.13. Rentschler Biopharma SE
16.1.14. Samsung Biologics
16.1.15. Thermo Fisher Scientific Inc.
16.1.16. Toyobo Co., Ltd.
16.1.17. WuXi Biologics, Inc.
16.2. Key Product Portfolio
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
FIGURE 3. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET DYNAMICS
FIGURE 7. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 10. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2023 VS 2030 (%)
FIGURE 12. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
FIGURE 14. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2023 VS 2030 (%)
FIGURE 16. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2023 VS 2030 (%)
FIGURE 18. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 28. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 9. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL-BASED BIOLOGICS OR NON-MAMMALIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 12. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL-AND-FINISHED, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 15. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QUALITY CONTROL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 20. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 23. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 48. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 50. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 52. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 53. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 54. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 58. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 80. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 82. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 83. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 84. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 85. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 86. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 88. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 89. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 90. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 91. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 98. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 100. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 101. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 102. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 103. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 134. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 136. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 137. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 138. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 139. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 153. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 155. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 156. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 157. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 158. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 159. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 161. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 162. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 163. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 164. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 165. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 167. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 168. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 169. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 170. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 173. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 174. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 175. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 176. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 177. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 180. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 181. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 182. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 189. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 191. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 192. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 193. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 194. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 207. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 209. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 210. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 211. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 212. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 213. POLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. POLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 215. POLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 216. POLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 217. POLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 218. POLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 219. QATAR BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. QATAR BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 221. QATAR BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 222. QATAR BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 223. QATAR BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 224. QATAR BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 243. SPAIN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. SPAIN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 245. SPAIN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 246. SPAIN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 247. SPAIN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 248. SPAIN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 261. TURKEY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. TURKEY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 263. TURKEY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 265. TURKEY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 266. TURKEY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 279. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 280. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 281. BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET LICENSE & PRICING

Companies Mentioned

  • AbbVie, Inc.
  • AGC Biologics
  • Ajinomoto Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • FUJIFILM Diosynth Biotechnologies
  • INCOG BioPharma Services
  • JRS PHARMA GmbH + Co. KG
  • Lonza AG
  • Merck KGaA
  • Pressure BioSciences
  • ProBioGen AG
  • Rentschler Biopharma SE
  • Samsung Biologics
  • Thermo Fisher Scientific Inc.
  • Toyobo Co., Ltd.
  • WuXi Biologics, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 43.43 Billion
Forecasted Market Value ( USD ) by 2030 $ 108.17 Billion
Compound Annual Growth Rate16.3%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions - Product Image

Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions

  • Report
  • 799 Pages
  • Global
From
Global Biologics Contract Manufacturing Market by Product (Biosimilar, Insulin, Interferons), Platform (Mammalian, Microbial), Therapeutic Area, Scale of Operation - Forecast 2024-2030 - Product Image

Global Biologics Contract Manufacturing Market by Product (Biosimilar, Insulin, Interferons), Platform (Mammalian, Microbial), Therapeutic Area, Scale of Operation - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Global Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Forecast 2024-2030 - Product Image

Global Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Biopharmaceuticals Contract Manufacturing Global Market Report 2024 - Product Image

Biopharmaceuticals Contract Manufacturing Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Biopharmaceutical contract manufacturing Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Biopharmaceutical contract manufacturing Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From

About the Biopharmaceutical Contract Manufacturing Market

Biopharmaceutical Contract Manufacturing (CMO) is a service provided by specialized companies to biopharmaceutical companies. CMOs provide a range of services, from drug development and manufacturing to packaging and distribution. These services are tailored to the specific needs of the biopharmaceutical company, allowing them to focus on their core competencies. CMOs are able to provide a wide range of services, including process development, analytical testing, clinical trial materials, and commercial manufacturing. They also provide regulatory support, helping biopharmaceutical companies to navigate the complex regulatory landscape. CMOs are an important part of the biopharmaceutical industry, providing a cost-effective and efficient way to develop and manufacture drugs. Companies in the market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto Bio-Pharma Services. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.